| Place of Origin: | China |
|---|---|
| Brand Name: | HNB |
| Certification: | ISO |
| Model Number: | Ceftriaxone sodium |
| Minimum Order Quantity: | 1KG |
| Price: | Negotiable |
| Packaging Details: | Aluminum foil bag |
| Delivery Time: | Usually7-10days |
| Payment Terms: | L/C, D/A, D/P, T/T, Western Union, MoneyGram |
| Supply Ability: | 5000kg/Month |
| CAS: | 74578-69-1 | Mf: | C18H19N8NaO7S3 |
|---|---|---|---|
| MW: | 578.57 | Specification: | ≥98% |
| Einecs No.: | 277-930-0 | Appearance: | White Or Off White Crystalline Powder |
| High Light: | 98% Antibiotic Ceftriaxone Sodium Powder,CAS 74578-69-1 Ceftriaxone Sodium Powder,CAS 74578-69-1 third generation cephalosporins |
||
CAS 73231-34-2 Veterinary API Antibiotic Ceftriaxone sodium
|
Product Name |
Ceftriaxone sodium |
|---|---|
CAS No. |
74578-69-1 |
Molecular Formula |
C18H17N8NaO7S3 |
Molecular Weight |
576.56200 |
PSA |
296.63000 |
LogP |
-2.03600 |
The Introductction of Ceftriaxone sodium:
Ceftriaxone sodium as a semi-synthetic third-generation cephalosporins, for most Gram-positive bacteria and-negative bacteria have strong antibacterial activity, antibacterial spectrum, including Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, bacterial intestinal gas production , Proteus, and Staphylococcus aureus meningitis is so. The drug on β-lactamase stability.
The Application & Function of Ceftriaxone sodium:
The main clinical infection for susceptible strains of meningitis, pneumonia, skin and soft tissue infections, peritonitis, urinary tract infections, gonorrhea, liver and gallbladder infection, surgical trauma, sepsis, and genital infections. As a treatment for gonorrhea has been first-line drugs.
Ceftriaxone injection is often used (in combination, but not direct, with macrolide and/oraminoglycoside antibiotics) for the treatment of community-acquired or mild to moderate health care-associated pneumonia. It is also a choice drug for treatment of bacterial meningitis. In pediatrics, it is commonly used in febrile infants between 4 and 8 weeks of age who are admitted to the hospital to exclude sepsis.
The COA of Ceftriaxone sodium:
| Items | Standard | Result |
| Appearance | White to yellow-orange crystalline powder | Off-white crystalline powder |
| Identification | Conforms | Conforms |
| Crystallinity | Conforms | Conforms |
| PH | 6.0-8.0 | 7.4 |
| Water | 8.0-11.0% | 9.4% |
| Related substances | Impurity A≤0.5% | 0.01% |
| Impurity B.C≤0.5% | 0.01% | |
| Impurity D≤1.0% | 0.1% | |
| Impurity E≤0.2% | Note detected | |
| Impurity F≤0.5% | 0.04% | |
| Impurity G≤0.5% | 0.03% | |
| Impurity H≤0.5% | 0.02% | |
| Any individual unspecified impurity ≤0.2% | 0.004% | |
| Total impurities ≤2.5% | 0.2% | |
| Bacterial endotoxins | <0.20EU/mg | <0.20EU/mg |
